Hinge Health (NYSE:HNGE) President James Pursley Sells 33,000 Shares

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 33,000 shares of the firm’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $69.31, for a total value of $2,287,230.00. Following the transaction, the president owned 740,897 shares in the company, valued at approximately $51,351,571.07. This trade represents a 4.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Pursley also recently made the following trade(s):

• On Tuesday, May 26th, James Pursley sold 16,000 shares of Hinge Health stock. The stock was sold at an average price of $53.79, for a total value of $860,640.00.

Hinge Health Stock Performance

HNGE opened at $70.01 on Wednesday. The company has a market cap of $5.42 billion and a PE ratio of -5.67. The stock has a 50-day moving average of $54.80 and a 200-day moving average of $47.01. Hinge Health Inc. has a 52-week low of $30.08 and a 52-week high of $71.44.

Hinge Health (NYSE:HNGE) last posted its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.33. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The firm had revenue of $182.31 million during the quarter. During the same quarter last year, the firm posted $1.30 earnings per share. The firm’s revenue for the quarter was up 47.2% compared to the same quarter last year. On average, research analysts predict that Hinge Health Inc. will post 1.33 earnings per share for the current year.

Hedge Funds Weigh In On Hinge Health

Several large investors have recently bought and sold shares of the stock. Wells Fargo & Company MN grew its position in Hinge Health by 160.0% in the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after purchasing an additional 336 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in shares of Hinge Health during the fourth quarter valued at about $26,000. CENTRAL TRUST Co acquired a new position in shares of Hinge Health during the first quarter valued at about $37,000. First Horizon Corp lifted its stake in shares of Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock valued at $40,000 after buying an additional 531 shares during the period. Finally, High Point Wealth Management LLC acquired a new stake in Hinge Health during the fourth quarter worth about $46,000.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on HNGE shares. Barclays raised their target price on shares of Hinge Health from $62.00 to $70.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Robert W. Baird boosted their target price on shares of Hinge Health from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 17th. Raymond James Financial upped their price target on shares of Hinge Health from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Monday, June 15th. Truist Financial lifted their price objective on Hinge Health from $79.00 to $85.00 and gave the stock a “buy” rating in a research note on Thursday, June 11th. Finally, Evercore reissued an “outperform” rating and set a $45.00 price objective on shares of Hinge Health in a research report on Wednesday, April 8th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Hinge Health currently has a consensus rating of “Moderate Buy” and an average price target of $75.80.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.